News|Podcasts|November 10, 2022
An Invitation to Define the Lab of the Future
Author(s)LabVantage Solutions
Today’s labs are not sufficient to handle tomorrow’s challenges. What will labs in 2030 or 2040 look like? Mikael Hagstroem, CEO at LabVantage Solutions and expert in harnessing data and analytics, discusses the three phases of digital transformation needed to reimagine business models, achieve better performance, and create long-term sustainable advantage. It starts with changing our labs – the technologies, processes, ways of working, and data solutions.
Related Content
Trending on PharmExec
1
The Biotech Industry’s Relationship with Real-Time Data: Q&A with Dr. Richard Graham
2
Does FDA's Shift From Two Pivotal Trials to One Represent a Genuine Evolution?
3
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
4
The Evolving Relationship Between FDA and Biotech
5